0001209191-17-037520.txt : 20170605
0001209191-17-037520.hdr.sgml : 20170605
20170605080301
ACCESSION NUMBER: 0001209191-17-037520
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160602
FILED AS OF DATE: 20170605
DATE AS OF CHANGE: 20170605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intellia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001652130
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 364785571
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-285-6200
MAIL ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DORSA CAROLINE
CENTRAL INDEX KEY: 0001181174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37766
FILM NUMBER: 17889949
MAIL ADDRESS:
STREET 1: BIOGEN INC.
STREET 2: 225 BINNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-02
0
0001652130
Intellia Therapeutics, Inc.
NTLA
0001181174
DORSA CAROLINE
C/O INTELLIA THERAPEUTICS, INC.
40 ERIE STREET; SUITE 130
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2017-06-02
4
A
0
5000
12.42
A
5000
D
/s/ Nicole Heifner, attorney-in-fact
2017-06-05